Today's Research Reports on Trending Tickers: Amarin Corporation and Sage Therapeutics
NEW YORK, NY / ACCESSWIRE / January 7, 2019 /U.S. markets surged on Friday as employment data came in well above expectations. The Bureau of Labor Statistics reported 312,000 jobs were added in December, soaring past the expected increase of 182,000 jobs, according to economists polled by MarketWatch. The Dow Jones Industrial Average hiked 3.29 percent to close at 23,433.16, while the S&P 500 Index jumped 3.43 percent to close at 2,531.94. The Nasdaq Composite Index advanced 4.26 percent to close at 6,738.86.
According to Willie Delwiche, the Director and Investment Strategist of R.W. Baird & Co., the upbeat employment data and wage growth continues to beat expectations, “it makes it very difficult to argue that the Fed should come to a complete halt in hiking interest rates, or that the economy is meaningfully weakening.”
The Market Edge Initiates Coverage on:
Amarin Corporation plc
https://marketedgereport.com/report/AMRN/
Sage Therapeutics, Inc.
https://marketedgereport.com/report/SAGE/
Amarin Corporation’ stock jumped 4.68% Friday, to close the day at $13.20. The stock recorded a trading volume of 7,851,025 shares, which was below its three months average volume of 10,917,890 shares. In the last year, Amarin Corporation’ shares have traded in a range of 2.35 - 23.34. The share price has gained 461.7% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $15.90 is above its 200-day moving average of $10.58. Shares of Amarin Corporation have fallen roughly 26.63 percent in the past month and are up 202.06 percent in last one year.
Access The Market Edge's Amarin Corporation plc Research Report:
https://marketedgereport.com/report/AMRN/
On Friday, shares of Sage Therapeutics recorded a trading volume of 701,380 shares, which was above the three months average volume of 464,077 shares. The stock ended the day 9.16% higher at $97.51. The share price has fallen 50.24% from its 52 week high with a 52 week trading range of 79.88 - 195.97. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $101.60 is below its 200-day moving average of $134.71. Shares of Sage Therapeutics have fallen roughly 7.91 percent in the past month and are up 1.8 percent year-to-date.
Access The Market Edge's Sage Therapeutics, Inc. Research Report:
https://marketedgereport.com/report/SAGE/
Our Actionable Research on Amarin Corporation plc (NASDAQ:AMRN) and Sage Therapeutics, Inc. (NASDAQ:SAGE) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: MarketEdgeReport
